WILSON GAYLE E 4
4 · GILEAD SCIENCES INC · Filed Feb 11, 2020
Insider Transaction Report
Form 4
WILSON GAYLE E
Director
Transactions
- Exercise/Conversion
Common Stock
2020-02-10$19.63/sh+21,720$426,364→ 148,502 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2020-02-10−21,720→ 0 totalExercise: $19.63Exp: 2020-05-11→ Common Stock (21,720 underlying) - Sale
Common Stock
2020-02-10$67.72/sh−21,720$1,470,878→ 126,782 total
Footnotes (2)
- [F1]Sale prices reported for the transactions reported here range from $67.71 to $67.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F2]The options vesed quarterly over the first year of service and were fully vested on May 11, 2011.